Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132971) titled 'Using Artificial Intelligence to Analyze Ultrasound and Mammography Images for Distinguishing Benign from Malignant BI-RADS Category 4 Breast Lesions' on Sept. 20.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Affiliated Qingyuan Hospital, Guangzhou Medical University (Qingyuan People's Hospital)
Condition:
BI-RADS category 4 breast lesions
Intervention:
Group 1:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Group 1:385;Group 2:165;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org...